logo
logo

Multi-Million-Pound Impact Investment in George Institute Businesses to Fast-Track New Treatments for the World’s Biggest Killers

Mar 10, 2020over 5 years ago
London

Description

George Health, a profit-for-purpose company, today announces £27 million / $35 million of new financing to accelerate the commercialisation of affordable drug treatments and technologies for some of the world’s biggest killers. This funding round was led by Bupa Australia, Federation Asset Management and the Australian Government-backed Medical Research Commercialisation Fund Biomedical Translation Fund (MRCF BTF), managed by Brandon Capital Partners.

Company Information

Company

George

Location

London, Ontario, Canada

About

Twitter @GeorgeInstUK Web georgeinstitute.ox.ac.uk

Related People